Good News | Xingyue Biomedical Honored with the Title of "Yuhang District Technological Innovation Model Unit"

On the morning of March 2nd, the 2026 Yuhang District High-Quality Economic Development Conference, themed "Loyalty and Responsibility Write a New Chapter, Pragmatic and Striving to Lead a New Era," was grandly held in the Hangzhou Future Science and Technology City. The conference presented awards to enterprises and units that made outstanding contributions to the regional economy over the past year. Leveraging its innovative practices and industrialization achievements in the field of biomaterials, Xingyue Biomedical once again stepped onto the awards stage, being honored as a "Yuhang District Technological Innovation Model Unit." Mr. Zhao Hongshi, the General Manager of the company, attended the conference and received the award on behalf of the enterprise.

As a high-standard event marking the beginning of Yuhang District's "15th Five-Year Plan," this conference comprehensively summarized the achievements in regional economic development, anchored the "53311" development goals, and aimed to drive high-quality regional economic growth with new quality productive forces. The conference brought together representatives from government departments, leading research institutions, prestigious universities, key enterprises, and investment firms, all witnessing the remarkable progress Yuhang District has made in economic development, technological innovation, and other areas. Xingyue Biomedical, deeply engaged in the research, development, and industrialization of silk fibroin, received this award alongside outstanding enterprises in fields such as the digital economy, advanced manufacturing, and life sciences. This fully demonstrates Yuhang District's high recognition and strong support for hardcore technology and original innovation.

Benefiting from Yuhang District's iteratively upgraded industrial policies and its technological innovation ecosystem, Xingyue Biomedical has consistently focused on the core field of medical silk biomaterials. Rooted in its core silk fibroin technology, the company continuously expands its dual-wheel-driven industrial landscape encompassing "medical + consumer" sectors, building a comprehensive industrial chain covering wound repair, tissue regeneration, high-end medical aesthetics, and efficacy skincare. To date, the company has accumulated numerous invention patents, establishing a robust patent protection matrix. Its independently developed Class III medical device products have achieved the critical leap from the laboratory to clinical application, propelling China's medical silk materials from a position of following to leading on the global stage.

Looking ahead, against the backdrop of Yuhang District's strategy to become the core hub for building the nation's "First City of Artificial Intelligence Innovation and Development," Xingyue Biomedical will remain rooted in Yuhang, serve the nation, and look towards the global market. The company will actively explore new models of biomaterial R&D, leveraging intelligent technologies to accelerate new material development, clinical trials, and the translation of achievements. With the innovative resilience symbolized by "a single strand of silk," it will continuously enhance product quality and technological standards, fully contributing to overcoming critical technological bottlenecks in the application of silk in biomedical materials, and injecting new momentum into the development of the region's new quality productive forces.